BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9330762)

  • 1. The antiviral xanthate compound D609 inhibits herpes simplex virus type 1 replication and protein phosphorylation.
    Walro DG; Rosenthal KS
    Antiviral Res; 1997 Sep; 36(1):63-72. PubMed ID: 9330762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of HIV-1 replication by an antiviral xanthate compound in vitro.
    Mellert W; Amtmann E; Erfle V; Sauer G
    AIDS Res Hum Retroviruses; 1988 Feb; 4(1):71-81. PubMed ID: 3365357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the phosphorylation of the regulatory non-structural protein of vesicular stomatitis virus by an antiviral xanthate compound.
    Müller-Decker K; Amtmann E; Sauer G
    J Gen Virol; 1987 Dec; 68 ( Pt 12)():3045-56. PubMed ID: 2447222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral effects of xanthate D609 on the human respiratory syncytial virus growth cycle.
    Villanueva N; Navarro J; Cubero E
    Virology; 1991 Mar; 181(1):101-8. PubMed ID: 1994569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of DNA synthesis in untransformed cells by the antiviral and antitumoral compound tricyclodecan-9-yl-xanthogenate (D609).
    Kiss Z; Crilly KS; Chung T
    Biochem Pharmacol; 1998 Mar; 55(6):915-8. PubMed ID: 9586966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of dual sites of action of dendrimers: SPL-2999 inhibits both virus entry and late stages of herpes simplex virus replication.
    Gong Y; Matthews B; Cheung D; Tam T; Gadawski I; Leung D; Holan G; Raff J; Sacks S
    Antiviral Res; 2002 Aug; 55(2):319-29. PubMed ID: 12103432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of Us8A and Its Phosphorylation Mediated by Us3 in Herpes Simplex Virus 1 Pathogenesis.
    Kato A; Ando T; Oda S; Watanabe M; Koyanagi N; Arii J; Kawaguchi Y
    J Virol; 2016 Jun; 90(12):5622-5635. PubMed ID: 27030266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol suppresses nuclear factor-kappaB in herpes simplex virus infected cells.
    Faith SA; Sweet TJ; Bailey E; Booth T; Docherty JJ
    Antiviral Res; 2006 Dec; 72(3):242-51. PubMed ID: 16876885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of herpes simplex virus replication by a 2-amino thiazole via interactions with the helicase component of the UL5-UL8-UL52 complex.
    Spector FC; Liang L; Giordano H; Sivaraja M; Peterson MG
    J Virol; 1998 Sep; 72(9):6979-87. PubMed ID: 9696789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiviral, antitumoural xanthate D609 is a competitive inhibitor of phosphatidylcholine-specific phospholipase C.
    Amtmann E
    Drugs Exp Clin Res; 1996; 22(6):287-94. PubMed ID: 9034754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance of mRNA translation to acute endoplasmic reticulum stress-inducing agents in herpes simplex virus type 1-infected cells requires multiple virus-encoded functions.
    Mulvey M; Arias C; Mohr I
    J Virol; 2006 Aug; 80(15):7354-63. PubMed ID: 16840316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and biochemical characterization of the protein kinase encoded by the US3 gene of herpes simplex virus type 2.
    Daikoku T; Yamashita Y; Tsurumi T; Maeno K; Nishiyama Y
    Virology; 1993 Dec; 197(2):685-94. PubMed ID: 8249291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential inhibition of 5-trifluoromethyl-2'-deoxyuridine phosphorylation by 5'-amino-5'-deoxythymidine in uninfected versus herpes simplex virus-infected cells.
    Fischer PH; Murphy DG; Kawahara R
    Mol Pharmacol; 1983 Jul; 24(1):90-6. PubMed ID: 6408395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of a herpes simplex virus 1 dUTPase by a viral protein kinase, Us3, dictates viral pathogenicity in the central nervous system but not at the periphery.
    Kato A; Shindo K; Maruzuru Y; Kawaguchi Y
    J Virol; 2014 Mar; 88(5):2775-85. PubMed ID: 24352467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for antiviral activity of glutathione: in vitro inhibition of herpes simplex virus type 1 replication.
    Palamara AT; Perno CF; Ciriolo MR; Dini L; Balestra E; D'Agostini C; Di Francesco P; Favalli C; Rotilio G; Garaci E
    Antiviral Res; 1995 Jun; 27(3):237-53. PubMed ID: 8540746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a Herpes Simplex Virus 1 (HSV-1) Chimera in Which the Us3 Protein Kinase Gene Is Replaced with the HSV-2 Us3 Gene.
    Shindo K; Kato A; Koyanagi N; Sagara H; Arii J; Kawaguchi Y
    J Virol; 2016 Jan; 90(1):457-73. PubMed ID: 26491159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of virus-encoded thymidine kinase suppresses herpes simplex virus replication in vitro and in vivo.
    Watkins AM; Dunford PJ; Moffatt AM; Wong-Kai-In P; Holland MJ; Pole DS; Thomas GM; Martin J; Roberts NA; Mulqueen MJ
    Antivir Chem Chemother; 1998 Jan; 9(1):9-18. PubMed ID: 9875372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral effects of 28-deacetylsendanin on herpes simplex virus-1 replication.
    Kim M; Kim SK; Park BN; Lee KH; Min GH; Seoh JY; Park CG; Hwang ES; Cha CY; Kook YH
    Antiviral Res; 1999 Sep; 43(2):103-12. PubMed ID: 10517312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BX-795 inhibits HSV-1 and HSV-2 replication by blocking the JNK/p38 pathways without interfering with PDK1 activity in host cells.
    Su AR; Qiu M; Li YL; Xu WT; Song SW; Wang XH; Song HY; Zheng N; Wu ZW
    Acta Pharmacol Sin; 2017 Mar; 38(3):402-414. PubMed ID: 28112176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of tyrphostin on the replication of herpes simplex virus type 1.
    Yura Y; Kusaka J; Kondo Y; Tsujimoto H; Yoshida H; Sato M
    Arch Virol; 1995; 140(7):1181-94. PubMed ID: 7544112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.